Trial
NCT04810611
Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Myelodysplastic Syndromes
Intervention
MBG453
Why stopped
Business reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-10